SCHEMBL7363044

SCHEMBL7363044

COc1cc(-c2csc(N)n2)cc(OC)c1OC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
NPC1 O15118 2/20 0.59
RAB9A P51151 2/20 0.59
SMN1; SMN2 Q16637 2/20 0.59
MEN1 O00255 2/20 0.59
KMT2A Q03164 2/20 0.59
MAPT P10636 2/20 0.56
POLB P06746 2/20 0.56
GAA P10253 1/20 0.55
MAPK1 P28482 1/20 0.55
HSD17B10 Q99714 1/20 0.53
KDM4E B2RXH2 2/20 0.51
GFER P55789 1/20 0.49
LTA4H P09960 3/20 0.49
TSHR P16473 1/20 0.47
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27428414 0.86 ALDH1A1 (0.59) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL16003853 0.83 ALDH1A1 (0.56) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL21547855 0.83 GAA (0.63) ALDH1A1NPC1SMN1; SMN2MEN1KMT2A
SCHEMBL427925 0.81 MEN1 (0.75) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL1801918 0.81 ALDH1A1 (0.66) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL17400558 0.81 ALDH1A1 (0.54) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
Bromide SCHEMBL8360766 0.80 NPC1 (0.73) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL1308428 0.79 TUBB4A (0.61) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL18471273 0.79 ALDH1A1 (0.67) ALDH1A1NPC1RAB9ASMN1; SMN2MEN1
SCHEMBL21366341 0.79 GFER (0.52) ALDH1A1MEN1KMT2AMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106220582-A N, 4 diaryl thiazole 2 aminated compoundss and the purposes as tumor cell proliferation inhibitor thereof 沈阳药科大学 2016-12-14 CN disclosed
CN-104418821-A 2, 4-substituted 5- (3,4, 5-trimethoxyphenyl) thiazole derivative and preparation method and application thereof WEST CHINA HOSPITAL SICHUAN UNIV 2015-03-18 CN disclosed
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed
WO-2002046129-A2 INHIBITORS OF HISTONE DEACETYLASE ABBOTT LABORATORIES (US) 2002-06-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 ALDH1A1 302/4885NPC1 285/4885RAB9A 2823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.